Editorial: Host-microbe immunometabolic chat: a new era of organismal communication

• by Marco Gargaro, Francesca Fallarino, Teresa Zelante

• May 29, 2026

Nuclear receptor PPARγ targets GPNMB to promote oligodendrocyte development and remyelination

• by Bing Han, Ming-Yue Bao, Qing-Qing Sun, Rui-Ning Wang, Xin Deng, Kun Xing, Feng-Lin Yu, Yan Zhang, Yue-Bo Li, Xiu-Qing Li, Na-Nan Chai, Gai-Xin Ma, Ya-Na Yang, Meng-Yuan Tian, Qian Zhang, Xing Li, Yuan Zhang

• January 6, 2025

Now Enrolling: Real-World Registry Study of BRUMVI (Ublituximab-xiiy) in Relapsing Multiple Sclerosis

Baptist Health Brain & Spine Care is enrolling patients with confirmed multiple sclerosis who are starting BRUMVI to track outcomes, safety, and patient experience over time in a real-world setting.

• by

• March 4, 2026

• 2 min

The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis

• by Gavin Giovannoni, Louisa James, Adekunle A Adeniran, Julian Gold, Lawrence S Young, David L Selwood, David Baker, Ruth Dobson

• May 6, 2025